(Q28330674)

English

Cisplatin, ifosfamide and vindesine in the chemotherapy of non-small-cell lung cancer: a combination phase II study

scientific article

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Cisplatin, ifosfamide and vindesine in the chemotherapy of non-small-cell lung cancer: a combination phase II study (English)

0 references

0 references

1 reference

1 reference

R Honda

1

0 references

A Fujita

series ordinal

2

0 references

Y Inoue

series ordinal

3

0 references

M Asakawa

series ordinal

4

0 references

A Suzuki

series ordinal

5

0 references

language of work or name

English

0 references

publication date

1990

0 references

published in

Cancer Chemotherapy and Pharmacology

0 references

volume

26

0 references

page(s)

373-6

0 references

issue

5

0 references

cites work

Ifosfamide-induced subclinical tubular nephrotoxicity despite mesna.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2170045

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination chemotherapy with ifosfamide, mitomycin, and cisplatin in advanced non-small cell lung cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2170045

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potentiation of ifosfamide neurotoxicity, hematotoxicity, and tubular nephrotoxicity by prior cis-diamminedichloroplatinum(II) therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2170045

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New agents in non-small cell lung cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2170045

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2170045

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mitomycin, ifosfamide and cisplatin in non-small-cell lung cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2170045

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: A randomized trial investigating two dosage schedules

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2170045

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of vindesine plus cisplatin or vindesine plus mitomycin in the treatment of advanced non-small cell lung cancer.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2170045

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial comparing vindesine plus cisplatin with vinblastine plus cisplatin in patients with non-small cell lung cancer, with an analysis of methods of response assessment

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2170045

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mitomycin C, vinblastine and cisplatin combination chemotherapy in the treatment of advanced non-small cell lung cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2170045

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination chemotherapy with cisplatin, etoposide, and vindesine in non-small cell lung carcinoma: a clinical trial of the EORTC lung cancer working party

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2170045

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ifosfamide by bolus as treatment for advanced non-small cell lung cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2170045

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/BF02897297

0 references

Dimensions Publication ID

1015186937

0 references

PubMed ID

2170045

0 references

Springer Nature article ID

10.1007/bf02897297

0 references

(Q28330674)

Cisplatin, ifosfamide and vindesine in the chemotherapy of non-small-cell lung cancer: a combination phase II study

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)